Patents by Inventor Kevin Maloney

Kevin Maloney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12257932
    Abstract: A transportation system is disclosed. The transportation system includes a vehicle, a plurality of seating assemblies positioned within a passenger compartment of the vehicle and defining an arrangement, a plurality of actuators that effect movement of various components of the plurality of seating assemblies, a plurality of sensors, and a controller. Specific examples of pre-set or pre-programmed arrangements are disclosed, as well as the ability to customize the arrangement. Additionally, exemplary methods are disclosed that illustrate transitions between a variety of the pre-set or pre-programmed arrangements.
    Type: Grant
    Filed: November 9, 2020
    Date of Patent: March 25, 2025
    Assignee: Ford Global Technologies, LLC
    Inventors: Marcos Silva Kondrad, Patrick Maloney, Kevin Mozurkewich, Johnathan Andrew Line, Robert Parenti
  • Patent number: 12207766
    Abstract: A cutting apparatus having a ratcheting and non-ratcheting configuration for cutting food. The cutting apparatus includes a pair of handles with a cutting blade having a toothed portion and a non-toothed portion. In the ratcheting configuration, the cutting blade is held in position by a position holder, engaging the toothed portion of the cutting apparatus. In the non-ratcheting configuration, the position holder engages a separate non-toothed portion of the cutting blade. Additionally, in the non-ratcheting configuration, a bottom bar and top mechanism bar allows for the cutting apparatus to be locked into the non-ratcheting configuration.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: January 28, 2025
    Inventors: Zachary Kevin Brandt, Paul Andrew McMahon, Ryan Christopher Maloney
  • Patent number: 11834491
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Grant
    Filed: March 30, 2021
    Date of Patent: December 5, 2023
    Assignee: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Publication number: 20210309719
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Application
    Filed: March 30, 2021
    Publication date: October 7, 2021
    Applicant: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Patent number: 10995130
    Abstract: Aspects of the invention are directed to arginine-free polypeptide-containing compositions and methods for treating disorders associated with inflammation or the autoimmune response. In particular, the polypeptide is etanercept.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: May 4, 2021
    Assignee: Biogen MA Inc.
    Inventors: Kevin Maloney, Ke Gong, Roy Alston
  • Publication number: 20210069300
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 11, 2021
    Inventors: Kevin MALONEY, Daniel GAGE, Ahmad ABDUL-FATTAH
  • Patent number: 10786554
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: September 29, 2020
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Kevin Maloney, Daniel Gage, Ahmad Abdul-Fattah
  • Publication number: 20190325408
    Abstract: A system for secure transactions of information is provided herein, where the system includes a computing device having a software application installed thereon and is configured to store a public cryptocurrency key and a hardware encryption device configured to store a private encryption key, and is configured to selectively connect in data communication to the computing device for signing an cryptocurrency transaction. The computing device broadcasts a signed transaction received from the hardware encryption device for verification of the transaction.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 24, 2019
    Applicant: Xeeda Inc.
    Inventors: Marc Goroff, Kevin Maloney, Seyed Parham Sadrizadeh, Amirhossein Mansourighasri
  • Publication number: 20190307035
    Abstract: This invention relates to a new and distinctive variety of a Malus xdomestica apple tree named ‘NY109’, particularly characterized by its overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, juicy, high sugar and high acid and flavorful fruit with great potential for marketing as both a fresh apple and as value-added processed apple products, such as for hard and sweet cider and for baking, is disclosed.
    Type: Application
    Filed: March 30, 2018
    Publication date: October 3, 2019
    Inventors: Susan Brown, Kevin Maloney
  • Publication number: 20190141870
    Abstract: A new and distinctive variety of a Malus domestica apple tree named ‘NY56’, particularly characterized by its overall horticultural performance and consistency including resistance to apple scab and excellent fruit quality at harvest by having crisp, juicy and flavorful fruit, is disclosed.
    Type: Application
    Filed: November 7, 2017
    Publication date: May 9, 2019
    Inventors: Susan BROWN, Kevin MALONEY
  • Publication number: 20170281734
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Application
    Filed: March 9, 2017
    Publication date: October 5, 2017
    Applicant: Bioverativ Therapeutics Inc.
    Inventors: Kevin MALONEY, Daniel Gage, Ahmad Abdul-Fattah
  • Patent number: 9623088
    Abstract: The present invention provides a formulation of a Factor VIII polypeptide, e.g., FVIII-Fc, and methods of using the same. The FVIII polypeptide can be a recombinant FVIII protein, a short-acting FVIII protein, or a long-acting FVIII protein. The pharmaceutical formulation comprising a FVIII polypeptide can be used for individual prophylaxis, weekly prophylaxis, episodic (on-demand) treatment, or perioperative management of hemophilia.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: April 18, 2017
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Kevin Maloney, Daniel Gage, Ahmad Abdul-Fattah
  • Patent number: 9533044
    Abstract: Formulations of VLA-4 binding antibody are described.
    Type: Grant
    Filed: June 22, 2012
    Date of Patent: January 3, 2017
    Assignee: BIOGEN MA INC.
    Inventor: Kevin Maloney
  • Publication number: 20160175816
    Abstract: Systems and methods are disclosed herein for synthesizing ammonia using nano-size metal or metal alloy catalyst particles. Hydrogen and nitrogen gases are passed through a system comprising, for example, a bed of magnetite supporting nano-size iron or iron alloy catalyst particles having an optional oxide layer that forms the catalyst.
    Type: Application
    Filed: February 26, 2016
    Publication date: June 23, 2016
    Inventors: R. Douglas Carpenter, Kevin Maloney
  • Patent number: 9272920
    Abstract: Systems and methods are disclosed herein for synthesizing ammonia using nano-size metal or metal alloy catalyst particles. Hydrogen and nitrogen gases are passed through a system comprising, for example, a bed of magnetite supporting nano-size iron or iron alloy catalyst particles having an optional oxide layer that forms the catalyst.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: March 1, 2016
    Assignee: QuantumSphere, Inc.
    Inventors: R. Douglas Carpenter, Kevin Maloney
  • Publication number: 20150211674
    Abstract: The disclosed invertible structures rely on combinations of translational movements to effect inversion. An exemplary invertible structure includes a track operable to be slidably coupled to at least two connectors of a longitudinal structure. The track may have a slot having a plurality of translational axes for translational movements of the connectors of the longitudinal structure that would effect the inversion of the longitudinal structure.
    Type: Application
    Filed: November 25, 2014
    Publication date: July 30, 2015
    Applicant: UCP INTERNATIONAL CO. LTD
    Inventors: David Jalbert, David Simonelli, Diane Eaker, Kevin Maloney
  • Patent number: D806958
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: January 2, 2018
    Assignee: Vet Innovations, LLC
    Inventor: Kevin Maloney
  • Patent number: PP30758
    Abstract: A new and distinctive variety of a Malus domestica apple tree named ‘NY56’, particularly characterized by its overall horticultural performance and consistency including resistance to apple scab and excellent fruit quality at harvest by having crisp, juicy and flavorful fruit, is disclosed.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: July 30, 2019
    Assignee: CORNELL UNIVERSITY
    Inventors: Susan Brown, Kevin Maloney
  • Patent number: PP31145
    Abstract: This invention relates to a new and distinctive variety of a Malus x domestica apple tree named ‘NY109’, particularly characterized by its overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, juicy, high sugar and high acid and flavorful fruit with great potential for marketing as both a fresh apple and as value-added processed apple products, such as for hard and sweet cider and for baking, is disclosed.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: December 3, 2019
    Assignee: Cornell University
    Inventors: Susan Brown, Kevin Maloney
  • Patent number: PP32702
    Abstract: A new and distinctive variety of a Malus x domestica apple tree named ‘NY73’, particularly characterized by its attractive fruit appearance, unique pink blush, overall superior horticultural performance and consistency, including excellent fruit quality at harvest by having firm, crisp, juicy, and flavorful fruit with great potential for marketing as both a fresh apple and in u-pick, retail, and wholesale operations is disclosed.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: December 29, 2020
    Assignee: CORNELL UNIVERSITY
    Inventors: Susan K. Brown, Kevin Maloney